PRE HOSPITAL
- ABCs
- Observe universal precautions
- IV access if indicated
- Transport to burn center if >30% of body surface involved
INITIAL STABILIZATION/THERAPY
- Endotracheal intubation and ventilatory support may be required for impending respiratory failure (more commonly associated with TEN)
- IV fluids
ED TREATMENT/PROCEDURES
- Fluid replacement:
- Fluid losses may be significant
- Recognize and treat underlying infections:
- Sepsis is the primary cause of death, frequently from gram-negative pneumonia
- Secondarily infected cutaneous lesions can be treated with débridement of blisters, compresses, and systemic antibiotics
- Corticosteroids are controversial
- Prophylactic antibiotics may be indicated if systemic steroids are given
- Intravenous immunoglobulin (IVIG) may be beneficial
- Mild systemic symptoms may be treated with acetaminophen or NSAIDs provided they are not the cause of the mucocutaneous reaction
- Mucous membrane lesions are extremely painful and may require parenteral analgesics
- Large extensive bullae should be débrided, ideally in a burn unit
MEDICATION
- Acetaminophen: 500 mg PO/PR q4–6h (peds: 10–15 mg/kg/dose; do not exceed 5 doses/24 h); do not exceed 4 g/24 h
- Acyclovir: 5–10 mg/kg IV q8h (for herpes simplex virus infections)
- Ibuprofen: 300–800 mg PO (peds: 5–10 mg/kg/dose)
- Morphine sulfate: 0.1 mg/kg/dose IV
First Line
- Fluid replacement
- Treat underlying etiology
- Treat secondary infections
- Analgesia
Second Line
FOLLOW-UP
DISPOSITION
Admission Criteria
- Patients with SJS should be admitted to the hospital
- Patients with extensive epidermal detachment should be admitted to a burn center or a specialized intensive care unit
Discharge Criteria
Patients with EM minor may be discharged with appropriate and timely follow-up
Issues for Referral
Patients must be made aware of the likely offending drug (and its class) and that it must never be administered to them again
FOLLOW-UP RECOMMENDATIONS
Follow-up with PCP and/or dermatologist
PEARLS AND PITFALLS
- SJS may begin like an influenza illness. Lesions appear 1–3 days after the prodrome
- The diagnosis is clinical and biopsy is supportive
- M. pneumoniae
and herpes simplex are more common triggers in children than in adults
ADDITIONAL READING
- Gerull R, Nelle M, Schaible T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: A review.
Crit Care Med.
2011;39:1521–1532.
- James JD, Berger TG, Elston DM.
Andrew’s Clinical Dermatology.
10th ed. Philadelphia, PA: Saunders; 2006.
- Lee HY, Dunant A, Sekula P. The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: A case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies.
Br J Dermatol.
2012;167:555–562.
- Levi N, Bastuji-Garin S, Mockenhaupt M, et al. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: A pooled analysis.
Pediatrics
. 2009;123:e297–e304.
- Stella M, Clemente A, Bollero D, et al. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): Experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis.
Burns
. 2007;33:452–459.
- Wolff K, Johnson RA, Suurmond D. Stevens-Johnson syndrome and toxic epidermal necrolysis. In:
Fitzpatrick’s Color Atlas & Synopsis of Clinical Dermatology.
5th ed. New York, NY: McGraw-Hill, 2005:144–147.
See Also (Topic, Algorithm, Electronic Media Element)
- Erythema Multiforme
- Toxic Epidermal Necrolysis
CODES
ICD9
- 695.13 Stevens-Johnson syndrome
- 695.14 Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome
ICD10
- L51.1 Stevens-Johnson syndrome
- L51.3 Stevens-Johnson synd-tox epdrml necrolysis overlap syndrome
STING, BEE
Daniel T. Wu
BASICS
DESCRIPTION
- Injection of hymenoptera venom causes:
- Release of biologic amines
- Local or systemic allergic reactions
- Reactions are:
- Usually IgE-mediated type I hypersensitivity reactions
- Rarely type III (Arthus) hypersensitivity reactions
ETIOLOGY
- Hymenoptera—order of the phylum Arthropoda
- Includes bees (Apidae family), wasps and hornets (Vespidae family), fire ants (Formicidae family)
DIAGNOSIS
SIGNS AND SYMPTOMS
History
History and physical exam—keys to diagnosis
Physical-Exam
5 types of reactions to stings:
- Local reaction:
- Most common type of reaction
- Local pain, erythema, and edema at sting site
- Symptoms occur immediately and resolve within 1–2 hr
- Large local reaction:
- Similar to local reaction but affects larger area or entire limbs
- Peaks at 48 hr and can last several days
- Mild to moderate fever
- Systemic reaction:
- Includes anaphylaxis
- Can be fatal (usually owing to respiratory failure)
- Respiratory:
- Wheezing
- Coughing
- Stridor
- Shortness of breath
- Hoarseness
- Angioedema
- GI:
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Cardiovascular:
- Hypotension
- Chest pain
- Tachycardia
- Shock
- Other:
- Urticaria
- Pruritus
- Flushing
- Symptoms occur within 15–20 min and last ≤72 hr
- Toxic reaction:
- Result of multiple stings and large doses of venom
- Symptoms similar to anaphylaxis
- Unusual reactions:
- Owing to unusual immune response
- Vasculitis
- Nephrosis
- Serum sickness
- Neuritis
- Encephalitis
- Reaction delayed (days to weeks after sting)
ESSENTIAL WORKUP
- History and physical exam key to diagnosis
- No radiologic or lab test will confirm hymenoptera envenomation or anaphylaxis
DIAGNOSIS TESTS & NTERPRETATION
Lab
- CBC, electrolytes, BUN, creatinine, glucose, arterial blood gases (ABGs):
- Not routine
- Consider when significant systemic effects present
Diagnostic Procedures/Surgery
ECG:
- When significant systemic effects present in patients at risk for cardiovascular disease
DIFFERENTIAL DIAGNOSIS
- Insect bites sometimes cause pain; stings always cause pain.
- Cellulitis:
- Difficult to distinguish between large local reactions and cellulitis
- Infections of hymenoptera envenomations are rare and usually caused by wasp envenomations.
- Local reaction can resemble periorbital cellulitis.
- Gout
- Soft tissue trauma
- Systemic/toxic reactions:
- Pulmonary embolus
- Anaphylaxis from different agent
- Hyperventilatory syndrome/anxiety
- Acute coronary syndrome